Among all patients who received chemotherapy there were no appreciable differences, in either the HM vs NHM or Apobec vs Other analyses, between the comparison subgroups in terms of tumor alterations in TP53, RB1 or DNA damage repair (DDR) genes. Here, TP53 is linked to neoplasm.